Streetbeat News

Stock Prices

NRBO

NeuroBo Pharmaceuticals (NASDAQ:NRBO) announced pre-clinical data showing that its novel drug DA-1726 is superior in weight loss, lean body mass retention, and lipid-lowering effects compared to survodutide. The data will be presented at the ADA 2024 Scientific Sessions.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:06 am

MNKD

MannKind Corporation (NASDAQ:MNKD) announced positive 17-week results from the INHALE-3 study, a Phase 4 U.S. clinical trial evaluating Afrezza® (inhaled insulin) vs. usual care. The study met its primary efficacy endpoint, showing non-inferior changes in HbA1c and better glycemic target achievement in the inhaled insulin group.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:04 am

TERN

Terns Pharmaceuticals (NASDAQ:TERN) announced preclinical data for its obesity treatment, TERN-501, which will be presented at the ADA 2024 Scientific Sessions. The data highlights the combination of TERN-501, a THR-β receptor agonist, with a GLP-1 receptor agonist.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 6:59 am

MDT

Medtronic plc (NYSE:MDT) presented new data at the American Diabetes Association's 84th Scientific Sessions showcasing the benefits of its MiniMed™ 780G system in addressing hyperglycemia and reducing nighttime burden for diabetes patients. The data highlights significant improvements in managing high blood sugar levels and reducing sleep disruptions compared to the previous MiniMed™ 770G system.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 6:57 am

PODD

Insulet Corporation (NASDAQ:PODD) announced positive results from its Omnipod 5 Automated Insulin Delivery System pivotal trial for type 2 diabetes at the ADA 84th Scientific Sessions. The trial showed significant glycemic improvements, reduced HbA1c, and improved time in range without increasing hypoglycemia.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 6:56 am

DOGEUSD

PEPEUSD

RUNESUSD

Crypto analyst Michaël van de Poppe criticizes meme coins but highlights Dogecoin (DOGE), Bitcoin-based DOG (RUNES), and Pepe (PEPE) as having potential for high returns. Despite a current downturn in these coins, he forecasts an altcoin market rebound in the coming weeks.

Portfolio Pulse from Aniket Verma

June 24, 2024 | 5:25 am

TSLA

Gary Black, Managing Partner at Future Fund, criticized Delaware judges for overstepping their roles in a Tesla Inc. (NASDAQ:TSLA) case involving Elon Musk's $56 billion pay package. The Delaware General Assembly passed Senate Bill 313 to restrain judicial activism, reflecting ongoing tensions between the judiciary and legislative bodies.

Portfolio Pulse from Benzinga Neuro

June 24, 2024 | 4:41 am

BTCUSD

ETHUSD

Nate Geraci, president of The ETF Institute, anticipates approvals for spot Ethereum ETFs this week, potentially shaking up the cryptocurrency market. This follows his earlier prediction and comments from the SEC. Analysts predict a potential 60% rally in Ether's price if the ETFs are approved.

Portfolio Pulse from Aniket Verma

June 24, 2024 | 4:18 am

AAPL

META

Apple's development of its AR smart glasses, Apple Glass, is still in early stages and may not be ready until after 2027. This delay contrasts with Meta's recent launch of Ray-Ban smart glasses featuring Meta AI.

Portfolio Pulse from Ananya Gairola

June 24, 2024 | 3:12 am

MSFT

NVDA

Nvidia's market capitalization has surged past $3 trillion, driven by the demand for its GPUs crucial to the AI boom. However, its brand recognition lags behind tech giants like Apple, Microsoft, Amazon, and Google. Despite this, Nvidia's brand value is catching up, ranking No. 6 in Kantar BrandZ's list of valuable global brands. CEO Jensen Huang has recently sold over $90 million in shares amid concerns about future earnings.

Portfolio Pulse from Benzinga Neuro

June 24, 2024 | 2:47 am